Shipments of Moderna COVID-19 vaccines are due to arrive in Taiwan next month, while another batch of AstraZeneca vaccines allotted to Taiwan under the COVAX program is due to arrive by June, the Central Epidemic Command Center (CECC) said yesterday.
The Chinese-language Apple Daily reported that the Moderna vaccines might arrive at the end of this month or next month.
The center in February said that Moderna had agreed to supply about 5 million doses to Taiwan, although at the time the center estimated that they would arrive in the middle of this year.
Photo: Reuters
Centers for Disease Control Deputy Director-General Chuang Jen-hsiang (莊人祥), who is the CECC’s spokesman, said that 9,470 additional AstraZeneca shots had been sent to 68 medical facilities to expedite the rollout.
The CECC would also provide shots to local health departments, Chuang said, amid reports that vaccinations are lagging due to wariness among the public.
The Apple Daily quoted National Taiwan University Children’s Hospital pediatrician Huang Li-min (黃立民) as saying that low administration rates of the AstraZeneca vaccine was due to safety doubts, not people failing to heed CECC recommendations to get the jab.
The AstraZeneca vaccine has been linked to unusual blood clots, resulting in reluctance to get the shots, Huang said, adding that the Moderna vaccines should not draw the same skepticism.
The CECC is moving forward with the vaccine rollout, Chuang said.
The Food and Drug Administration has been asked to contact the manufacturers of the vaccines and inquire about extending their shelf life.
Two shipments of AstraZeneca vaccines expire on May 31 and June 15.
Regulations say that the manufacturer must conduct a stability test before an application to extend a shelf life can be submitted, Chuang said.
In the worst case, the expiration date would be unalterable and the vaccines disposed of, he said.
Asked about Denmark’s decision to stop its rollout of AstraZeneca vaccines completely, Chuang said that nations have their own considerations and standards, citing decisions in the US and Australia to halt inoculations with the Johnson & Johnson vaccine, while France is pushing forward with that product.
Including 1,319 people given the the AstraZeneca vaccine on Wednesday, Taiwan has inoculated 28,465 people, Chuang said.
Twelve cases of an adverse event following immunization were reported on Wednesday, but the cases were not severe, he said.
The CECC yesterday announced one additional confirmed case of imported COVID-19, designated case No. 1,069.
A Taiwanese aged under five who had been living in Indonesia arrived in Taiwan on March 28 with case No. 1,036, the CECC said.
CRITICAL MOVE: TSMC’s plan to invest another US$100 billion in US chipmaking would boost Taiwan’s competitive edge in the global market, the premier said The government would ensure that the most advanced chipmaking technology stays in Taiwan while assisting Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) in investing overseas, the Presidential Office said yesterday. The statement follows a joint announcement by the world’s largest contract chipmaker and US President Donald Trump on Monday that TSMC would invest an additional US$100 billion over the next four years to expand its semiconductor manufacturing operations in the US, which would include construction of three new chip fabrication plants, two advanced packaging facilities, and a research and development center. The government knew about the deal in advance and would assist, Presidential
‘DANGEROUS GAME’: Legislative Yuan budget cuts have already become a point of discussion for Democrats and Republicans in Washington, Elbridge Colby said Taiwan’s fall to China “would be a disaster for American interests” and Taipei must raise defense spending to deter Beijing, US President Donald Trump’s pick to lead Pentagon policy, Elbridge Colby, said on Tuesday during his US Senate confirmation hearing. The nominee for US undersecretary of defense for policy told the Armed Services Committee that Washington needs to motivate Taiwan to avoid a conflict with China and that he is “profoundly disturbed” about its perceived reluctance to raise defense spending closer to 10 percent of GDP. Colby, a China hawk who also served in the Pentagon in Trump’s first team,
SEPARATE: The MAC rebutted Beijing’s claim that Taiwan is China’s province, asserting that UN Resolution 2758 neither mentions Taiwan nor grants the PRC authority over it The “status quo” of democratic Taiwan and autocratic China not belonging to each other has long been recognized by the international community, the Mainland Affairs Council (MAC) said yesterday in its rebuttal of Beijing’s claim that Taiwan can only be represented in the UN as “Taiwan, Province of China.” Chinese Minister of Foreign Affairs Wang Yi (王毅) yesterday at a news conference of the third session at the 14th National People’s Congress said that Taiwan can only be referred to as “Taiwan, Province of China” at the UN. Taiwan is an inseparable part of Chinese territory, which is not only history but
INVESTMENT WATCH: The US activity would not affect the firm’s investment in Taiwan, where 11 production lines would likely be completed this year, C.C. Wei said Investments by Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) in the US should not be a cause for concern, but rather seen as the moment that the company and Taiwan stepped into the global spotlight, President William Lai (賴清德) told a news conference at the Presidential Office in Taipei yesterday alongside TSMC chairman and chief executive officer C.C. Wei (魏哲家). Wei and US President Donald Trump in Washington on Monday announced plans to invest US$100 billion in the US to build three advanced foundries, two packaging plants, and a research and development center, after Trump threatened to slap tariffs on chips made